The Intersection of Biotechnology and Health Issues in IP Law: RIPL's Special Issue 2011

This edition of John Marshall RIPL: the 2011 Special Issue, with seven cutting-edge articles from recognized lawyers and scholars of IP law and biotechnology and health sciences. Topics include encouraging biotech innovation by patent, risks & advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, materiality doctrine for inequitable conduct; genetics; more. More

One of the leading IP law journals in the world presents it second special symposium issue to go ebook (the 2010 issue, available as well, centered on the "green" movement and its intellectual property law issues). This edition of John Marshall RIPL is the new 2011 Special Issue, with seven cutting-edge articles from recognized lawyers and scholars of IP law and biotechnology and health sciences.

Each spring, RIPL produces a symposium law review issue. In this important contribution, RIPL presents very current articles on emerging biotech research and industries, and their promotion through IP law, including patents and trademarks. Topics include encouraging biotech innovation through patent protection, the risks and advantages of DIY scientists, plain packaging of tobacco, research funding of small projects, the materiality doctrine for inequitable conduct, patenting genetic materials, EU law on patent infringement, and health care reform's effect on drug research.

The volume is also useful and accessible to non-lawyers interested in these issues and the way they are affected by legal and policy decisions.